Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis.
Vale DL, Freitas CS, Martins VT, Moreira GJL, Machado AS, Ramos FF, Pereira IAG, Bandeira RS, de Jesus MM, Tavares GSV, Ludolf F, Chávez-Fumagalli MA, Galdino AS, Fujiwara RT, Bueno LL, Roatt BM, Christodoulides M, Coelho EAF, Lage DP. Vale DL, et al. Among authors: de jesus mm. Biology (Basel). 2023 Jun 13;12(6):851. doi: 10.3390/biology12060851. Biology (Basel). 2023. PMID: 37372136 Free PMC article.
Immunotherapy Using Immunogenic Mimotopes Selected by Phage Display plus Amphotericin B Inducing a Therapeutic Response in Mice Infected with Leishmania amazonensis.
Soyer TG, Ramos FF, Pereira IAG, Lage DP, Bandeira RS, de Jesus MM, Costa GP, Machado AS, Freitas CS, Vale DL, Martins VT, Galdino AS, Chávez-Fumagalli MA, Menezes-Souza D, Duarte MC, Roatt BM, Coelho EAF, Tavares GSV. Soyer TG, et al. Among authors: de jesus mm. Pathogens. 2023 Feb 14;12(2):314. doi: 10.3390/pathogens12020314. Pathogens. 2023. PMID: 36839586 Free PMC article.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.
Freitas CS, Santiago SS, Lage DP, Antinarelli LMR, Oliveira FM, Vale DL, Martins VT, Magalhaes LND, Bandeira RS, Ramos FF, Pereira IAG, de Jesus MM, Ludolf F, Tavares GSV, Costa AV, Ferreira RS, Coimbra ES, Teixeira RR, Coelho EAF. Freitas CS, et al. Among authors: de jesus mm. Exp Parasitol. 2023 Aug;251:108555. doi: 10.1016/j.exppara.2023.108555. Epub 2023 May 27. Exp Parasitol. 2023. PMID: 37247802
The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice.
Lage DP, Martins VT, Vale DL, Freitas CS, Pimenta BL, Moreira GJL, Ramos FF, Pereira IAG, Bandeira RS, de Jesus MM, Ludolf F, Tavares GSV, Chávez-Fumagalli MA, Roatt BM, Christodoulides M, Coelho EAF. Lage DP, et al. Among authors: de jesus mm. Acta Trop. 2023 Oct;246:106986. doi: 10.1016/j.actatropica.2023.106986. Epub 2023 Jul 14. Acta Trop. 2023. PMID: 37453579
Immunotherapy Combining Mimotopes Selected by Phage Display Plus Amphotericin B Is Effective for Treatment Against Visceral Leishmaniasis.
Soyer TG, Bandeira Câmara RS, Pereira IAG, Ramos FF, de Jesus MM, Ludolf F, de Paula Costa G, Lage DP, de Freitas CS, Vale DL, Pimenta BL, Martins VT, Galdino AS, Chávez-Fumagalli MA, Roatt BM, de Sousa Vieira Tavares G, Coelho EAF. Soyer TG, et al. Among authors: de jesus mm. Parasite Immunol. 2024 May;46(5):e13037. doi: 10.1111/pim.13037. Parasite Immunol. 2024. PMID: 38720446
14 results